search
Back to results

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children

Primary Purpose

Urinary Incontinence, Daytime Wetting, Urination Disorders

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Sacral TENS
Sponsored by
Aalborg University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Urinary Incontinence focused on measuring Transcutaneous Electrical Nerve Stimulation, TENS, Functional Magnetic Resonance Imaging, fMRI

Eligibility Criteria

6 Years - 14 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Overactive Bladder as per International Children's Continence Society criteria (cases only). At least 2 incontinence episodes per week (cases only). No urinary tract symptoms (healthy participants only). More than 3 daily urinations. Normal clinical examination. Exclusion Criteria: Known urogenital abnormality affecting the lower urinary tract function. Prior surgery in the urinary tract (except circumcision). Known neurological diseases or prior cerebral surgery. Known neuropsychiatric disorders or suspicion of those by screening. Treatment with pharmacological agents affecting the brain function. Prior treatment with Enuresis Alarm or Transcutaneous Electrical Nerve Stimulation. Prior or current treatment with mirabegron or oxybutynin. Current urinary tract infection. Current constipation according to Rome IV-criteria or faecal incontinence. Claustrophobia. Metallic items in the body contraindicating MRI-scans. Abnormal uroflowmetry (healthy participants only).

Sites / Locations

  • Department of Pediatrics, Aalborg University HospitalRecruiting
  • Department of Pediatrics, Aarhus University Hospital
  • Department of Pediatrics, Regional Hospital West Jutland
  • Department of Pediatrics, North Denmark Regional Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Transcutaneous Electric Nerve Stimulation (TENS)

Arm Description

Sacral TENS

Outcomes

Primary Outcome Measures

Activity in brain areas controlling the bladder
Blood Oxygen Level Dependent (BOLD)-signals on functional MRIs, compared between children with Overactive Bladder and Daytime Urinary Incontinence and children without bladder symptoms.
Change in activity in brain areas controlling the bladder after TENS-treatment
Blood Oxygen Level Dependent (BOLD)-signals on functional MRIs, compared between responders and non-responders to TENS-treatment.

Secondary Outcome Measures

Structural differences on MRI among children with OAB and DUI and healthy children
Volume of brain areas involved in bladder control (e.g. lateral nuclei in pons, prefrontal cortex, anterior cingulate cortex (ACC), insula, periaqueductal grey (PAG), the pontine micturition center (PMC), and hypothalamus)
Differences in Quality of Life (QoL) between children with OAB and DUI and healthy children
Assessment of QoL using WHO-5 among children with OAB and DUI and compare to QoL among children without bladder symptoms.
Change in WHO-5 score among children with OAB and DUI at baseline and after the intervention.
Assessment of QoL using WHO-5 among children with OAB and DUI prior to and after ten weeks of sacral TENS-treatment. WHO-5 (World Health Organization Quality of Life Brief Version) is a validated tool, assessing QoL as a total percent-score (range 0-100). A high score indicates better QoL.
Change in PinQ score among children with OAB and DUI at baseline and after the intervention.
Assessment of QoL using PinQ among children with OAB and DUI prior to and after ten weeks of sacral TENS treatment. PinQ (Pediatric Incontinence Questionnaire) is a validated tool, assessing QoL as a total score (range 0-80). A lower score indicates better QoL.
Change in WHO-5 score among children with OAB and DUI compared among responders and non-responders to sacral TENS treatment.
Assessment of QoL using WHO-5 and compare among responders and non-responders to sacral TENS-treatment. WHO-5 (World Health Organization Quality of Life Brief Version) is a validated tool, assessing QoL as a total percent-score (range 0-100). A high score indicates better QoL.
Change in PinQ score among children with OAB and DUI compared among responders and non-responders to sacral TENS treatment.
Assessment of QoL using PinQ and compare among responders and non-responders to sacral TENS-treatment. PinQ (Pediatric Incontinence Questionnaire) is a validated tool, assessing QoL as a total score (range 0-80). A lower score indicates better QoL.
Differences in maximum voided volume among responders and non-responders to sacral TENS treatment
Differences in maximum voided volume (MVV) in milliliters as assessed by the frequency and volume chart, compared among responders and non-responders to sacral TENS treatment.
Differences in voiding frequency among responders and non-responders to sacral TENS treatment
Differences in voiding frequency as assessed by the frequency and volume chart, compared among responders and non-responders to sacral TENS treatment.
Differences in VAS Urgency among responders and non-responders to sacral TENS treatment
Differences in VAS Urgency (visual analogue scale for urgency) in percent with a higher percent indicating a higher degree of urgency, compared among responders and non-responders to sacral TENS treatment.
Differences in urinary incontinence severity scores among responders and non-responders to sacral TENS treatment
Differences in urinary incontinence severity scores as assessed by Dry Pie, compared among responders and non-responders to sacral TENS treatment.

Full Information

First Posted
May 31, 2023
Last Updated
August 4, 2023
Sponsor
Aalborg University Hospital
Collaborators
Aarhus University Hospital, Regional Hospital West Jutland, North Denmark Regional Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05989646
Brief Title
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
Official Title
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children, and Modulation of Brain Activity by Transcutaneous Electrical Nerve Stimulation - a Functional Magnetic Resonance Imaging Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 5, 2021 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aalborg University Hospital
Collaborators
Aarhus University Hospital, Regional Hospital West Jutland, North Denmark Regional Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to investigate whether the activity in brain areas controlling the bladder is different among children suffering from Overactive Bladder (OAB) and Daytime Urinary Incontinence (DUI) compared to age- and gender-matched healthy children without bladder symptoms. Moreover, the aim is to investigate if sacral transcutaneous electric nerve stimulation (TENS) has a central mechanism of action. Children with OAB and DUI will be recruited from involved pediatric departments, and functional magnetic resonance imaging (fMRI) will be performed before and after 10 weeks of sacral TENS. In healthy children without bladder symptoms, only the baseline fMRI will be performed.
Detailed Description
Daytime Urinary Incontinence (DUI) is a common condition among children affecting 2.1-21.8 % of children aged 4.5-17 years. DUI is most often caused by a functional overactive bladder (OAB) leading to urgent desire to void (urgency) and frequent urinations (frequency). In some children with functional OAB and DUI, the bladder detrusor is overactive when performing a urodynamic investigation, but this is not evident for all children suffering from OAB and DUI. The etiology of OAB and DUI is not yet fully established and might be multifactorial. A few studies among adults have shown that adult women with OAB and DUI has more activity in brain areas controlling the bladder compared to adult women without bladder symptoms. Moreover, one study among adult women has shown a decrease in brain activity in areas controlling the bladder after sacral TENS treatment. This has led to a hypothesis that increased activity in the brain is a pathophysiological mechanism of OAB and DUI. Brain activity among children with OAB and DUI has not yet been investigated. Therefore, the objectives of this study is: To investigate the activity in brain areas controlling the bladder among children with OAB and DUI and age- and gender-matched children without bladder symptoms AND To investigate if sacral TENS has a centrally modulatory effect on the brain activity in areas controlling the bladder among children with OAB and DUI. Methods: The study consists of two sub-studies. The first sub-study is a cross-sectional study, whereas the second sub-study is an interventional cohort study. Forty-five children with OAB and DUI and 20 healthy children without bladder symptoms will be recruited. The study includes one structural MRI as well as two sessions of functional MRIs (only one functional MRI for healthy participants), one session prior to and after 10 weeks of sacral TENS treatment. The functional MRI session consist of a functional MRI with full bladder followed by a functional MRI with empty bladder. Moreover, the study participants and/or their parents are asked to fill in frequency and volume charts, Dry Pie, screening tools to rule out attention deficit hyperactivity disorder and autism spectrum disorders, and quality of life-questionnaires (WHO-5 and PinQ).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence, Daytime Wetting, Urination Disorders, Urination Involuntary, Urologic Diseases, Lower Urinary Tract Symptoms, Urological Manifestations, Behavioral Symptoms, Mental Disorders, Elimination Disorders
Keywords
Transcutaneous Electrical Nerve Stimulation, TENS, Functional Magnetic Resonance Imaging, fMRI

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Cross-sectional and interventional cohort study
Masking
None (Open Label)
Allocation
N/A
Enrollment
65 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Transcutaneous Electric Nerve Stimulation (TENS)
Arm Type
Experimental
Arm Description
Sacral TENS
Intervention Type
Device
Intervention Name(s)
Sacral TENS
Other Intervention Name(s)
Urotherapy
Intervention Description
Sacral TENS applied two hours daily for 10 weeks
Primary Outcome Measure Information:
Title
Activity in brain areas controlling the bladder
Description
Blood Oxygen Level Dependent (BOLD)-signals on functional MRIs, compared between children with Overactive Bladder and Daytime Urinary Incontinence and children without bladder symptoms.
Time Frame
Baseline
Title
Change in activity in brain areas controlling the bladder after TENS-treatment
Description
Blood Oxygen Level Dependent (BOLD)-signals on functional MRIs, compared between responders and non-responders to TENS-treatment.
Time Frame
Baseline AND immediately after the intervention
Secondary Outcome Measure Information:
Title
Structural differences on MRI among children with OAB and DUI and healthy children
Description
Volume of brain areas involved in bladder control (e.g. lateral nuclei in pons, prefrontal cortex, anterior cingulate cortex (ACC), insula, periaqueductal grey (PAG), the pontine micturition center (PMC), and hypothalamus)
Time Frame
Baseline
Title
Differences in Quality of Life (QoL) between children with OAB and DUI and healthy children
Description
Assessment of QoL using WHO-5 among children with OAB and DUI and compare to QoL among children without bladder symptoms.
Time Frame
Baseline
Title
Change in WHO-5 score among children with OAB and DUI at baseline and after the intervention.
Description
Assessment of QoL using WHO-5 among children with OAB and DUI prior to and after ten weeks of sacral TENS-treatment. WHO-5 (World Health Organization Quality of Life Brief Version) is a validated tool, assessing QoL as a total percent-score (range 0-100). A high score indicates better QoL.
Time Frame
Baseline AND immediately after the intervention
Title
Change in PinQ score among children with OAB and DUI at baseline and after the intervention.
Description
Assessment of QoL using PinQ among children with OAB and DUI prior to and after ten weeks of sacral TENS treatment. PinQ (Pediatric Incontinence Questionnaire) is a validated tool, assessing QoL as a total score (range 0-80). A lower score indicates better QoL.
Time Frame
Baseline AND immediately after the intervention
Title
Change in WHO-5 score among children with OAB and DUI compared among responders and non-responders to sacral TENS treatment.
Description
Assessment of QoL using WHO-5 and compare among responders and non-responders to sacral TENS-treatment. WHO-5 (World Health Organization Quality of Life Brief Version) is a validated tool, assessing QoL as a total percent-score (range 0-100). A high score indicates better QoL.
Time Frame
Immediately after the intervention
Title
Change in PinQ score among children with OAB and DUI compared among responders and non-responders to sacral TENS treatment.
Description
Assessment of QoL using PinQ and compare among responders and non-responders to sacral TENS-treatment. PinQ (Pediatric Incontinence Questionnaire) is a validated tool, assessing QoL as a total score (range 0-80). A lower score indicates better QoL.
Time Frame
Immediately after the intervention
Title
Differences in maximum voided volume among responders and non-responders to sacral TENS treatment
Description
Differences in maximum voided volume (MVV) in milliliters as assessed by the frequency and volume chart, compared among responders and non-responders to sacral TENS treatment.
Time Frame
Baseline AND immediately after the intervention
Title
Differences in voiding frequency among responders and non-responders to sacral TENS treatment
Description
Differences in voiding frequency as assessed by the frequency and volume chart, compared among responders and non-responders to sacral TENS treatment.
Time Frame
Baseline AND immediately after the intervention
Title
Differences in VAS Urgency among responders and non-responders to sacral TENS treatment
Description
Differences in VAS Urgency (visual analogue scale for urgency) in percent with a higher percent indicating a higher degree of urgency, compared among responders and non-responders to sacral TENS treatment.
Time Frame
Baseline AND immediately after the intervention
Title
Differences in urinary incontinence severity scores among responders and non-responders to sacral TENS treatment
Description
Differences in urinary incontinence severity scores as assessed by Dry Pie, compared among responders and non-responders to sacral TENS treatment.
Time Frame
Baseline AND immediately after the intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Overactive Bladder as per International Children's Continence Society criteria (cases only). At least 2 incontinence episodes per week (cases only). No urinary tract symptoms (healthy participants only). More than 3 daily urinations. Normal clinical examination. Exclusion Criteria: Known urogenital abnormality affecting the lower urinary tract function. Prior surgery in the urinary tract (except circumcision). Known neurological diseases or prior cerebral surgery. Known neuropsychiatric disorders or suspicion of those by screening. Treatment with pharmacological agents affecting the brain function. Prior treatment with Enuresis Alarm or Transcutaneous Electrical Nerve Stimulation. Prior or current treatment with mirabegron or oxybutynin. Current urinary tract infection. Current constipation according to Rome IV-criteria or faecal incontinence. Claustrophobia. Metallic items in the body contraindicating MRI-scans. Abnormal uroflowmetry (healthy participants only).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristina Thorsteinsson, MD
Phone
+4597663372
Email
uroforsk@rn.dk
First Name & Middle Initial & Last Name or Official Title & Degree
SΓΈren HagstrΓΈm, MD, PhD
Phone
+4597663400
Email
uroforsk@rn.dk
Facility Information:
Facility Name
Department of Pediatrics, Aalborg University Hospital
City
Aalborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristina Thorsteinsson, MD
Phone
+4597660477
Email
uroforsk@rn.dk
Facility Name
Department of Pediatrics, Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Konstantinos Kamperis, MD, PhD
Phone
+4578430000
Email
kostas.kamperis@clin.au.dk
Facility Name
Department of Pediatrics, Regional Hospital West Jutland
City
Herning
ZIP/Postal Code
7400
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luise Borch, MD, PhD
Email
luise.borch@rm.dk
Facility Name
Department of Pediatrics, North Denmark Regional Hospital
City
HjΓΈrring
ZIP/Postal Code
9800
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mette Line Roed, MD, PhD
Email
mld@rn.dk

12. IPD Sharing Statement

Citations:
PubMed Identifier
30930018
Citation
Warner TC, Baandrup U, Jacobsen R, Boggild H, Aunsholt Ostergaard PS, Hagstrom S. Prevalence of nocturia and fecal and urinary incontinence and the association to childhood obesity: a study of 6803 Danish school children. J Pediatr Urol. 2019 May;15(3):225.e1-225.e8. doi: 10.1016/j.jpurol.2019.02.004. Epub 2019 Feb 15.
Results Reference
background
PubMed Identifier
31397011
Citation
von Gontard A, Overs C, Moritz AM, Thome-Granz S, Hussong J. Incontinence and headache in preschool children. Neurourol Urodyn. 2019 Nov;38(8):2280-2287. doi: 10.1002/nau.24134. Epub 2019 Aug 8.
Results Reference
background
PubMed Identifier
15043666
Citation
Gur E, Turhan P, Can G, Akkus S, Sever L, Guzeloz S, Cifcili S, Arvas A. Enuresis: prevalence, risk factors and urinary pathology among school children in Istanbul, Turkey. Pediatr Int. 2004 Feb;46(1):58-63. doi: 10.1111/j.1442-200X.2004.01824.x.
Results Reference
background
PubMed Identifier
20199496
Citation
Swithinbank LV, Heron J, von Gontard A, Abrams P. The natural history of daytime urinary incontinence in children: a large British cohort. Acta Paediatr. 2010 Jul;99(7):1031-6. doi: 10.1111/j.1651-2227.2010.01739.x. Epub 2010 Feb 25.
Results Reference
background
PubMed Identifier
31804751
Citation
Xing D, Wang YH, Wen YB, Li Q, Feng JJ, Wu JW, Jia ZM, Yang J, Sihoe JD, Song CP, Hu HJ, Franco I, Wen JG. Prevalence and risk factors of overactive bladder in Chinese children: A population-based study. Neurourol Urodyn. 2020 Feb;39(2):688-694. doi: 10.1002/nau.24251. Epub 2019 Dec 5.
Results Reference
background
PubMed Identifier
18829077
Citation
Chung JM, Lee SD, Kang DI, Kwon DD, Kim KS, Kim SY, Kim HG, Moon du G, Park KH, Park YH, Pai KS, Suh HJ, Lee JW, Cho WY, Ha TS, Han SW; Korean Enuresis Association. Prevalence and associated factors of overactive bladder in Korean children 5-13 years old: a nationwide multicenter study. Urology. 2009 Jan;73(1):63-7; discussion 68-9. doi: 10.1016/j.urology.2008.06.063. Epub 2008 Sep 30.
Results Reference
background
PubMed Identifier
27530266
Citation
Franco I. Overactive bladder in children. Nat Rev Urol. 2016 Sep;13(9):520-32. doi: 10.1038/nrurol.2016.152. Epub 2016 Aug 17.
Results Reference
background
PubMed Identifier
18490916
Citation
Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008 Jun;9(6):453-66. doi: 10.1038/nrn2401.
Results Reference
background
PubMed Identifier
18092336
Citation
Griffiths D, Tadic SD. Bladder control, urgency, and urge incontinence: evidence from functional brain imaging. Neurourol Urodyn. 2008;27(6):466-74. doi: 10.1002/nau.20549.
Results Reference
background
PubMed Identifier
17574871
Citation
Griffiths D, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage. 2007 Aug 1;37(1):1-7. doi: 10.1016/j.neuroimage.2007.04.061. Epub 2007 May 18.
Results Reference
background
PubMed Identifier
29630979
Citation
Weissbart SJ, Bhavsar R, Rao H, Wein AJ, Detre JA, Arya LA, Smith AL. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study. J Urol. 2018 Aug;200(2):382-388. doi: 10.1016/j.juro.2018.03.129. Epub 2018 Apr 6.
Results Reference
background
PubMed Identifier
31172280
Citation
Zuo L, Chen J, Wang S, Zhou Y, Wang B, Gu H. Intra- and inter-resting-state networks abnormalities in overactive bladder syndrome patients: an independent component analysis of resting-state fMRI. World J Urol. 2020 Apr;38(4):1027-1034. doi: 10.1007/s00345-019-02838-z. Epub 2019 Jun 6.
Results Reference
background

Learn more about this trial

Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children

We'll reach out to this number within 24 hrs